Leah Neufeld
Patrimonio netto: 147 694 $ in data 31/08/2026
Patrimonio netto: 147 694 $ in data 31/08/2026
Leah R.
Neufeld is currently Chief People Officer at Immuneering Corp.
since 2022.
Former positions include Chief Human Resources at Luzsana Biotechnology, Inc. from 2021 to 2022, Vice President-People at Prevail Therapeutics, Inc. from 2019 to 2021, Head-Human Resources at Intercept Pharmaceuticals, Inc. from 2015 to 2019, Global Head-Human Resources at NPS Pharmaceuticals, Inc. from 2014 to 2015, Director-Human Resources at Daiichi Sankyo Pharma, Inc. from 2009 to 2014, and Manager-Human Resources at Johnson & Johnson from 2002 to 2009.
Education includes undergraduate studies at American University and graduate studies at The Johns Hopkins University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 13/03/2026 | 29.598 ( 0,05% ) | 147 694 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNEERING CORPORATION | Ufficiale delle Risorse Umane | 20/10/2022 |
| Società | Posizione | Fine |
|---|---|---|
Luzsana Biotechnology, Inc.
Luzsana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Ufficiale delle Risorse Umane | 01/10/2022 |
| PREVAIL THERAPEUTICS INC. | Ufficiale delle Risorse Umane | 01/08/2021 |
| INTERCEPT PHARMACEUTICALS, INC. | Ufficiale delle Risorse Umane | 01/09/2019 |
| NPS PHARMACEUTICALS, INC. | Ufficiale delle Risorse Umane | 01/07/2015 |
Daiichi Sankyo Pharma, Inc.
Daiichi Sankyo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Ufficiale delle Risorse Umane | 01/01/2014 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatments of rare diseases | Health Technology |
Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
American University
American University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immuneering Corp.
Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
Daiichi Sankyo Pharma, Inc.
Daiichi Sankyo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Prevail Therapeutics, Inc.
Prevail Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for neurodegenerative diseases | Health Technology |
Luzsana Biotechnology, Inc.
Luzsana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale